Ken Herrmann has served on Aktis Oncology's board of directors since May 2024. Since 2016 he has been the Director and Chair of the Department of Nuclear Medicine at the Universitaetsmedizin Essen in Germany, and he was previously a tenured Associate Professor in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles. He received an MD and Doctorate in Medicine from Humboldt Universitaet Berlin and an MBA from the University of Zurich.